The role of regulatory T cells and TH17 cells in multiple myeloma.
Standard
The role of regulatory T cells and TH17 cells in multiple myeloma. / Braga, Walter M T; Atanackovic, Djordje; Colleoni, Gisele W B.
In: Clin Dev Immunol, Vol. 2012, 2012, p. 293479.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - The role of regulatory T cells and TH17 cells in multiple myeloma.
AU - Braga, Walter M T
AU - Atanackovic, Djordje
AU - Colleoni, Gisele W B
PY - 2012
Y1 - 2012
N2 - The development of multiple myeloma (MM) involves a series of genetic alterations and changes in the bone marrow microenvironment, favoring the growth of the tumor and failure of local immune control. Quantitative and functional alterations in CD4(+) and CD8(+) T cells have been described in MM. The balance between T regulatory cells (Treg) and T helper (Th) 17 cells represents one essential prerequisite for maintaining anti-tumor immunity in MM. Tregs play an important role in the preservation of self-tolerance and modulation of overall immune responses against infections and tumor cells. In MM patients, Tregs seem to contribute to myeloma-related immune dysfunction and targeting them could, therefore, help to restore and enhance vital immune responses. Th17 cells protect against fungal and parasitic infections and participate in inflammatory reactions and autoimmunity. The interplay of TGF-? and IL-6, expressed at high levels in the bone marrow of myeloma patients, may affect generation of Th17 cells both directly or via other pro-inflammatory cytokines and thereby modulate antitumor immune responses. A detailed analysis of the balance between Tregs and Th17 cells seems necessary in order to design more effective and less toxic modes of immunotherapy myeloma which still is an uncurable malignancy.
AB - The development of multiple myeloma (MM) involves a series of genetic alterations and changes in the bone marrow microenvironment, favoring the growth of the tumor and failure of local immune control. Quantitative and functional alterations in CD4(+) and CD8(+) T cells have been described in MM. The balance between T regulatory cells (Treg) and T helper (Th) 17 cells represents one essential prerequisite for maintaining anti-tumor immunity in MM. Tregs play an important role in the preservation of self-tolerance and modulation of overall immune responses against infections and tumor cells. In MM patients, Tregs seem to contribute to myeloma-related immune dysfunction and targeting them could, therefore, help to restore and enhance vital immune responses. Th17 cells protect against fungal and parasitic infections and participate in inflammatory reactions and autoimmunity. The interplay of TGF-? and IL-6, expressed at high levels in the bone marrow of myeloma patients, may affect generation of Th17 cells both directly or via other pro-inflammatory cytokines and thereby modulate antitumor immune responses. A detailed analysis of the balance between Tregs and Th17 cells seems necessary in order to design more effective and less toxic modes of immunotherapy myeloma which still is an uncurable malignancy.
KW - Humans
KW - CD8-Positive T-Lymphocytes/immunology/pathology
KW - Forkhead Transcription Factors/biosynthesis/immunology
KW - Immune Tolerance
KW - Interleukin-6/biosynthesis/immunology
KW - Multiple Myeloma/immunology/pathology
KW - T-Lymphocytes, Regulatory/immunology/pathology
KW - Th17 Cells/immunology/pathology
KW - Transforming Growth Factor beta/biosynthesis/immunology
KW - Tumor Markers, Biological/biosynthesis/immunology
KW - Humans
KW - CD8-Positive T-Lymphocytes/immunology/pathology
KW - Forkhead Transcription Factors/biosynthesis/immunology
KW - Immune Tolerance
KW - Interleukin-6/biosynthesis/immunology
KW - Multiple Myeloma/immunology/pathology
KW - T-Lymphocytes, Regulatory/immunology/pathology
KW - Th17 Cells/immunology/pathology
KW - Transforming Growth Factor beta/biosynthesis/immunology
KW - Tumor Markers, Biological/biosynthesis/immunology
U2 - 10.1155/2012/293479
DO - 10.1155/2012/293479
M3 - SCORING: Journal article
VL - 2012
SP - 293479
ER -
